Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association
Abstract Identifying dependable prognostic indicators is essential for the efficient management of metabolic dysfunction-associated steatotic liver disease (MASLD). The index of hemoglobin glycation (HGI) has been demonstrated to be closely linked to the onset and advancement of MASLD. Currently, no...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-82034-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841544682471948288 |
|---|---|
| author | Mengjie Zhao Ning Sun Yurong Cheng Wantong Zhang Jinjin Ji Qiuyan Li Fang Lu Weiliang Weng |
| author_facet | Mengjie Zhao Ning Sun Yurong Cheng Wantong Zhang Jinjin Ji Qiuyan Li Fang Lu Weiliang Weng |
| author_sort | Mengjie Zhao |
| collection | DOAJ |
| description | Abstract Identifying dependable prognostic indicators is essential for the efficient management of metabolic dysfunction-associated steatotic liver disease (MASLD). The index of hemoglobin glycation (HGI) has been demonstrated to be closely linked to the onset and advancement of MASLD. Currently, no studies have investigated the relationship between HGI and mortality rates among MASLD patients. This study analyzed data from the National Health and Nutrition Examination Surveys (NHANES) covering 1999 to 2018, involving 8,257 adult patients diagnosed with MASLD. The HGI was determined using a linear regression model that correlated hemoglobin A1c (HbA1c) with fasting plasma glucose (FPG). The study employed Kaplan-Meier survival curves and weighted Cox proportional hazards models to evaluate the independent association between HGI and mortality risk. The study utilized restricted cubic splines (RCS) to visually depict the relationship between HGI and mortality risk. Over a median follow-up duration of 97.0 months, there were 1,352 recorded deaths, among which 386 were attributed to cardiovascular disease (CVD). Participants were classified into two groups based on their HGI values: the high HGI group (≥ 0.4605) and the low HGI group (< 0.4605). The results from the weighted Cox proportional hazards model indicated that individuals in the high HGI group faced a significantly higher risk of all-cause mortality (HR 1.47, 95% CI 1.19–1.82, P < 0.001). However, no significant increase in CVD mortality risk was observed (HR 1.38, 95% CI 0.95–1.99, P = 0.090). The RCS analysis identified a U-shaped association between HGI and both all-cause mortality and CVD mortality, with critical points at -0.0564 and − 0.0573, respectively. Below the critical points, HGI was negatively correlated with all-cause mortality (HR 0.82, 95% CI: 0.72–0.92, P < 0.001) and not significantly associated with CVD mortality (HR 0.78, 95% CI: 0.57–1.07, P = 0.126). Above the critical points, HGI was significantly positively correlated with both all-cause mortality (HR 1.36, 95% CI: 1.20–1.53, P < 0.001) and CVD mortality (HR 1.44, 95% CI: 1.11–1.88, P = 0.007). Further subgroup and interaction analyses corroborated the reliability of these findings. HGI could potentially function as a useful and dependable marker for evaluating all-cause mortality and cardiovascular mortality in MASLD patients. |
| format | Article |
| id | doaj-art-93abdc8098844192b68fb755402a8dbe |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-93abdc8098844192b68fb755402a8dbe2025-01-12T12:20:39ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-024-82034-1Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped associationMengjie Zhao0Ning Sun1Yurong Cheng2Wantong Zhang3Jinjin Ji4Qiuyan Li5Fang Lu6Weiliang Weng7Xiyuan Hospital, China Academy of Chinese Medicine SciencesXiyuan Hospital, China Academy of Chinese Medicine SciencesBeijing University of Chinese MedicineXiyuan Hospital, China Academy of Chinese Medicine SciencesXiyuan Hospital, China Academy of Chinese Medicine SciencesXiyuan Hospital, China Academy of Chinese Medicine SciencesXiyuan Hospital, China Academy of Chinese Medicine SciencesXiyuan Hospital, China Academy of Chinese Medicine SciencesAbstract Identifying dependable prognostic indicators is essential for the efficient management of metabolic dysfunction-associated steatotic liver disease (MASLD). The index of hemoglobin glycation (HGI) has been demonstrated to be closely linked to the onset and advancement of MASLD. Currently, no studies have investigated the relationship between HGI and mortality rates among MASLD patients. This study analyzed data from the National Health and Nutrition Examination Surveys (NHANES) covering 1999 to 2018, involving 8,257 adult patients diagnosed with MASLD. The HGI was determined using a linear regression model that correlated hemoglobin A1c (HbA1c) with fasting plasma glucose (FPG). The study employed Kaplan-Meier survival curves and weighted Cox proportional hazards models to evaluate the independent association between HGI and mortality risk. The study utilized restricted cubic splines (RCS) to visually depict the relationship between HGI and mortality risk. Over a median follow-up duration of 97.0 months, there were 1,352 recorded deaths, among which 386 were attributed to cardiovascular disease (CVD). Participants were classified into two groups based on their HGI values: the high HGI group (≥ 0.4605) and the low HGI group (< 0.4605). The results from the weighted Cox proportional hazards model indicated that individuals in the high HGI group faced a significantly higher risk of all-cause mortality (HR 1.47, 95% CI 1.19–1.82, P < 0.001). However, no significant increase in CVD mortality risk was observed (HR 1.38, 95% CI 0.95–1.99, P = 0.090). The RCS analysis identified a U-shaped association between HGI and both all-cause mortality and CVD mortality, with critical points at -0.0564 and − 0.0573, respectively. Below the critical points, HGI was negatively correlated with all-cause mortality (HR 0.82, 95% CI: 0.72–0.92, P < 0.001) and not significantly associated with CVD mortality (HR 0.78, 95% CI: 0.57–1.07, P = 0.126). Above the critical points, HGI was significantly positively correlated with both all-cause mortality (HR 1.36, 95% CI: 1.20–1.53, P < 0.001) and CVD mortality (HR 1.44, 95% CI: 1.11–1.88, P = 0.007). Further subgroup and interaction analyses corroborated the reliability of these findings. HGI could potentially function as a useful and dependable marker for evaluating all-cause mortality and cardiovascular mortality in MASLD patients.https://doi.org/10.1038/s41598-024-82034-1HGIMASLDAll-cause mortalityCardiovascular mortality |
| spellingShingle | Mengjie Zhao Ning Sun Yurong Cheng Wantong Zhang Jinjin Ji Qiuyan Li Fang Lu Weiliang Weng Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association Scientific Reports HGI MASLD All-cause mortality Cardiovascular mortality |
| title | Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association |
| title_full | Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association |
| title_fullStr | Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association |
| title_full_unstemmed | Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association |
| title_short | Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association |
| title_sort | hemoglobin glycation index and mortality risk in metabolic dysfunction associated steatotic liver disease patients a novel u shaped association |
| topic | HGI MASLD All-cause mortality Cardiovascular mortality |
| url | https://doi.org/10.1038/s41598-024-82034-1 |
| work_keys_str_mv | AT mengjiezhao hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT ningsun hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT yurongcheng hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT wantongzhang hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT jinjinji hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT qiuyanli hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT fanglu hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation AT weiliangweng hemoglobinglycationindexandmortalityriskinmetabolicdysfunctionassociatedsteatoticliverdiseasepatientsanovelushapedassociation |